2012
DOI: 10.1016/j.bbrc.2012.03.099
|View full text |Cite
|
Sign up to set email alerts
|

Designation of enzyme activity of glycine-N-acyltransferase family genes and depression of glycine-N-acyltransferase in human hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
72
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(85 citation statements)
references
References 16 publications
9
72
1
Order By: Relevance
“…GLYAT enzyme activity reaches its peak at about 18 months of age, stays at this level until approximately the age of 40, and then declines slightly in the elderly (Temellini et al, 1993;Mawal et al, 1997). It has also recently been demonstrated that GLYAT expression is transcriptionally down-regulated in hepatocellular carcinoma specimens, and that diet influences the expression of GLYAT in the livers of rats (Matsuo et al, 2012;Wen et al, 2013). In the case of the South African isovaleric acidemia patients, factors other than polymorphisms of the GLYAT SA38 S17T/N156S TK1 S17T/N156S AMR01113 S17T/N156S/P295L ASN00404 S17T/N156S AMR00637 S17T/N156S AFR19438 S17T/N36S/N156S EUR00097 S17T/N156S AFR18487 S17T/N156S gene may therefore better explain the interindividual variation in responsiveness to glycine supplementation.…”
Section: Factors That Influence Interindividual Variation In Glycine mentioning
confidence: 95%
“…GLYAT enzyme activity reaches its peak at about 18 months of age, stays at this level until approximately the age of 40, and then declines slightly in the elderly (Temellini et al, 1993;Mawal et al, 1997). It has also recently been demonstrated that GLYAT expression is transcriptionally down-regulated in hepatocellular carcinoma specimens, and that diet influences the expression of GLYAT in the livers of rats (Matsuo et al, 2012;Wen et al, 2013). In the case of the South African isovaleric acidemia patients, factors other than polymorphisms of the GLYAT SA38 S17T/N156S TK1 S17T/N156S AMR01113 S17T/N156S/P295L ASN00404 S17T/N156S AMR00637 S17T/N156S AFR19438 S17T/N36S/N156S EUR00097 S17T/N156S AFR18487 S17T/N156S gene may therefore better explain the interindividual variation in responsiveness to glycine supplementation.…”
Section: Factors That Influence Interindividual Variation In Glycine mentioning
confidence: 95%
“…GLYATL1 encodes an enzyme that catalyzes arylacetyl transfer . In noncancerous tissue it was found to be highly expressed in liver and kidney, and to a lesser extent in pancreas, testis, ovary and stomach .…”
Section: Introductionmentioning
confidence: 99%
“…2,3 GLYATL1 encodes an enzyme that catalyzes arylacetyl transfer. 4,5 In noncancerous tissue it was found to be highly expressed in liver and kidney, and to a lesser extent in pancreas, testis, ovary and stomach. 6 Human glycine N-acyltransferases (GLYATL, GLYATL1, GLYATL2, and GLYATL3) are involved in conjugation of carboxylic acids to glycine and glutamine.…”
Section: Introductionmentioning
confidence: 99%
“…2e). These enzymes transfer an acyl group from acyl-CoA to the N-terminus of amino acids, mainly glycine (a reaction referred to as glycine conjugation) [32][33][34] . This reaction is important for the detoxification of xenobiotics, such as benzoate, because GLYATs target not only acyl-CoA but also xenobiotic acyl-CoA, which has the potential to sequester coenzyme A (CoASH) and inhibit several enzymes 34,35 .…”
Section: Resultsmentioning
confidence: 99%